The Drugs and Cosmetics Act, 1940
Central Act
- Act 23 of 1940
- Enacted: 1940-04-10
- In force from: 1940-04-10
- Ministry: Ministry of Health and Family Welfare
- Department: Department of Health and Family Welfare
- Status: no repeal is recorded
Contents
- Section 1 - Short title, extent and commencement.
- Section 2 - Application of other laws not barred.
- Section 3 - Definitions.
- Section 3A - Construction of references to any law not in force or any functionary not in existence in the State of Jammu and Kashmir.
- Section 4 - Presumption as to poisonous substances.
- Section 5 - The Drugs Technical Advisory Board.
- Section 6 - The Central Drugs Laboratory.
- Section 7 - The Drugs Consultative Committee.
- Section 7A - Sections 5 and 7 not to apply to Ayurvedic, Siddha or Unani drugs
- Section 8 - Standards of quality.
- Section 9 - Misbranded drugs.
- Section 9A - Adulterated drugs.
- Section 9B - Spurious drugs
- Section 9C - Misbranded cosmetics.
- Section 9D - Spurious cosmetics.
- Section 10 - Prohibition of import of certain drugs or cosmetics.
- Section 10A - Power of Central Government to prohibit import of drugs and cosmetics in public interest.
- Section 11 - Application of law relating to sea customs and powers of Customs officers.
- Section 12 - Power of Central Government to make rules.
- Section 13 - Offences
- Section 14 - Confiscation
- Section 15 - Jurisdiction.
- Section 16 - Standards of quality.
- Section 17 - Misbranded drugs
- Section 17A - Adulterated drugs.
- Section 17B - Spurious drugs.
- Section 17C - Misbranded cosmetics
- Section 17D - Spurious cosmetics.
- Section 17E - Adulterated cosmetics
- Section 18 - Prohibition of manufacture and sale of certain drugs and cosmetics
- Section 18A - Disclosure of the name of the manufacturer, etc.
- Section 18B - Maintenance of records and furnishing of information.
- Section 19 - Pleas.
- Section 20 - Government Analysts.
- Section 21 - Inspectors
- Section 22 - Powers of Inspectors.
- Section 23 - Procedure of Inspectors.
- Section 24 - Persons bound to disclose place where drugs or cosmetics are manufactured or kept.
- Section 25 - Reports of Government Analysts.
- Section 26 - Purchaser of drug or cosmetic enabled to obtain test or analysis.
- Section 26A - Powers of Central Government to regulate, restrict or prohibit manufacture, etc., of drug and cosmetic in public interest.
- Section 26B - Powers of Central Government to regulate or restrict, manufacture, etc., of drug in public interest.
- Section 27 - Penalty for manufacture, sale, etc., of drugs in contravention of this Chapter.
- Section 27A - Penalty for manufacture, sale, etc., of cosmetics in contravention of this Chapter.
- Section 28 - Penalty for non-disclosure of the name of the manufacturer, etc
- Section 28A - Penalty for not keeping documents, etc., and for non-disclosure of information.
- Section 28B - Penalty for manufacture, etc., of drugs or cosmetics in contravention of section 26A.
- Section 29 - Penalty for use of Government Analyst’s report for advertising.
- Section 30 - Penalty for subsequent offences.
- Section 31 - Confiscation.
- Section 31A - Application of provisions to Government departments.
- Section 32 - Cognizance of offences.
- Section 32A - Power of Court to implead the manufacturer, etc.
- Section 32B - Compounding of certain offences.
- Section 33 - Power of Central Government to make rules.
- Section 33A - Chapter not to apply to Ayurvedic, Siddha or Unani drugs.
- Section 33B - Application of Chapter IVA
- Section 33C - Ayurvedic and Unani Drugs Technical Advisory Board.
- Section 33D - The Ayurvedic, Siddha and Unani Drugs Consultative Committee
- Section 33E - Misbranded drugs.
- Section 33EE - Adulterated drugs
- Section 33EEA - Spurious drugs.
- Section 33EEB - Regulation of manufacture for sale of Ayurvedic, Siddha and Unani drugs
- Section 33EEC - Prohibition of manufacture and sale of certain Ayurvedic, Siddha and Unani drugs.
- Section 33EED - Power of Central Government to prohibit manufacture, etc., of Ayurvedic, Siddha or Unani drugs in public interest.
- Section 33F - Government Analysts
- Section 33G - Inspectors.
- Section 33H - Application of provisions of sections 22, 23, 24 and 25.
- Section 33-I - Penalty for manufacture, sale, etc., of Ayurvedic, Siddha or Unani drug in contravention of this Chapter.
- Section 33J - Penalty for subsequent offences
- Section 33K - Confiscation
- Section 33KA - Disclosure of name of manufacturer, etc
- Section 33KB - Maintenance of records and furnishing of informantion.
- Section 33L - Application of provisions to Government departments
- Section 33M - Cognizance of offences.
- Section 33N - Power of Central Government to make rules.
- Section 33-O - Power to amend First Schedule
- Section 33P - Power to give directions.
- Section 34 - Offences by companies.
- Section 34A - Offences by Government departments.
- Section 34AA - Penalty for vexatious search or seizure.
- Section 35 - Publication of sentences passed under this Act
- Section 36 - Magistrate’s power to impose enhanced penalties.
- Section 36A - Certain offences to be tried summarily.
- Section 36AB - Special Courts.
- Section 36AC - Offences to be cognizable and non-bailable in certain cases
- Section 36AD - Application of Code of Criminal Procedure, 1973 to proceedings before special Court.
- Section 36AE - Appeal and revision
- Section 37 - Protection of action taken in good faith.
- Section 38 - Rules to be laid before Parliament.
Rules and regulations under this Act
Notifications, orders, forms and other documents
Schedules (2)
Notifications (132)
- G.S.R 56E Amendment Rule 135A,145D
- Amendment of Rule 3A_CDTL, Chennai notified for Condoms_Section
- Amendment Rule 105A
- Drugs and Cosmetics (First Amendment) Rules, 2018
- BCS Classification and BABE studies_Section 12 and 33_D&C Act.
- Drugs and Cosmetics (Amendment) Rules, 2018
- Suspension of Letrozole for induction of Ovulation_Section
- Prohibits the manufacture, sale or distribution of Fixed Dose Combination of Pancreatin or Pancrelipase drugs for human_Section
- Revoke GSR 378E_Reg. Suspension of Analgin and all formulatins containing Analgin for human use.
- Amendment to D &C Rules_Perpetual Licensing and Joint Inspection_Section 12 and 33_D & C Act
- TB Reporting Notification
- Amendment in the notification regarding Prohibition of the manufacture, sale of ORS_Section
- Amendment of Drugs and Cosmetics Rule, 1945_labelling requirements of Medical devices_Sectionn
- Amendment of Shedule Y Apendix III_Animal Toxicity_Section
- Amendment in G.S.R. 82 dt. 10.02.2011
- Prohibition of test kits used in Antibody Detecting Rapid Diagnostic Test
- G.S.R 78E Amendment devices Rule 2017_ Section 12 and 33 _ D & C Act.
- Amendment in the notification regarding Prohibition of the manufacture, sale of Rimonaband_Section
- Amendment of Rule 75A, 76A, 78A , 83A,83AA.Schedule A_Section
- Amendment SchY_PMS, Sytematic Toxicity studies_Section
- Amendment of Rule 122_Requirements of blood bank_Section
- Corrigendum to G.S.R 46E
- Amendment of Shedule H_Etizoam was included_Section
- Amendment of Rule 122DAB, Schedule Y & Appendix XII_Section
- Corrigendum to G.S.R 826E
- Amendment of Drugs and Cosmetics Rule, 1945_Section
- Insertion of Rule 122E,Sch D, Sch.H,Sch.S,Sch.X_Section
- Amendment Schedule K_Words,figures, letters ommitted in form 20C_Sction
- Drugs and Cosmetics (Fourth Amendment) Rules, 2018
- Amendment of Rule 168_Section 33N_D&C Act
- Amendment of Rule 69,71,75,76_Section
- regulation of Oseltamivir Phosphate and Zanamivir_ Section 26B_ D&C Act.
- Amendment of Rule 3A_tests notified for NIB_Sectinon
- Sch Mlll (Rule 69,69A, 75,75A)
- Amendment of Rule 97A-Lablelling requirements for Food producing Animals_Section
- Amendment of Rule 122DA_Substitution of Explanation_122DA omitted_Section
- Corrigendum
- Amendment in the notification regarding Prohibition of import ofChloral Hydrate_Section
- Amendment in the notification regarding Prohibition of the manufacture, sale of Oxytetracycline and Demeclocycline Liquid Oral Preparations_Section
- Amendment of Rule 122F, 122G, Schedule F_Section
- Prohibition of the imports fo the serodignostic kit for diagnosis of tuberculosis_Section
- Amendment of Rule 157A_Ayurveda, Siddha, Unani_Section
- Prohibition of the manufacture, sale of all Ayurvedic Drugs licensed as tooth pastes, tooth powders containing tobacco_Section
- Amendment of Rule 122P
- Amendment in the Rule 49_Section
- Prohibition of the manufacture, sale and distribution of the said fixed dose combination_Section_Section
- Amendment of Rule 43A
- Amendment of Rule 3A_Section 12 and 33_D&C Act
- Prohibition of the manufacture, sale or distribution of FDC of Flupenthixole and Melitracen_Section
- suspension of the manufacture for sale, sale and distribution of Fixed dose combination of Flupenthixol+ Melitracen for human use_Section
- Amendment to notification regarding Prohibition of the manufacture and sale_Mepacrine Hydrochloride, Fenfluramine and Dexfenfluramine_Section
- Amendment of Rule 103A Additional of Rule
- Amendment in Shedule D(I) and Schedule D(II)_Section
- Prohibition of the manufacture, sale of the said FDCs_Section
- Amendment of Rule 69,75,76,122B Sch P_Section
- Amendment in the notification regarding Prohibition of the manufacture, sale of said drugs_Section
- Designation of Laboratories under Medical Devices Rules, 2017
- Amendment of Rule_Schedule M-I_Section12 and 33_D&C Act.
- Insertion of Rule 148C_Prohibition of testing of cosmetics on animals_Section
- Amendment in the notification regarding Prohibition of import of Methaqualone_Section
- Amendment in the Rule 3A_Ffunctions of laboratories in respect of IUD_Section
- Revoke GSR 379E_Reg. Pioglitazone Suspension
- Amendments in the Second Schedule_Class of drugs like vaccine, sera, toxines
- Amendment in the notification regarding Prohibition of the manufacture, sale fo FDC of Corticosteroid_Section
- Amendment to notification regarding Prohibition of the manufacture and sale of Fixed dose combination of Diazcpam and Diphenhydramine Hydrochloride_Section
- restriction for Oseltamivir Phosphate and Zanamivir_Section
- Amendment of Rule 43A_Addition of Vishakhapatnam Sea and air port_Section
- Amendment of Rule_Substitution of Schedule H_Section
- Prohibits the manufacture, sale of distribution of the valdecoxib and its formulation_Section
- Prohibition of the manufacture, sale or distribution of the serodignostic kit for diagnosis of tuberculosis
- Amendment of Rule 127_Addition of Titanium Dioxide coated mica pearlscent pigments_Section
- Amendment in the notification regarding Prohibition of the manufacture, sale of Fixed dose combinationf of Metoclopramide except combination of Metoclopramide with AspirinParacetamol_Section
- Amendment of Rule122E_Addition of Vaccines and r-DNA_Section
- Corrigendum to G.S.R. 270E
- Amendment of Rule 74, 74A, 74B,78,78A
- Amendment Schedule K-Production of Oxygen 93 percent_Section
- Amendment in the notification regarding Prohibition of manufacture, sale Fixed dose combination of Salbutamol or any other drug having primarily bronchdilatory activity with centrally acting anti-tussive andor antithistamine_Section
- Prohibition of the manufacture, sale or distribution of the Phenoformin_Section
- Drugs and Cosmetics (Third Amendment) Rules, 2018
- Amendment of Sch S, SchQ_Section 12& 33
- Prohibits the manufacture, sale and distribution of the said drugs for human use_Section
- Amendment of Rule 74, 78, 150E_Imlementation of Sch_L1_Section
- Amendment in Schedule I_Ayurvedic, Siddha Pharmacopeia and its parts_Section
- Revoke of suspension on Letrozole_Section 26_A D&C Act
- Amendment in the notification regarding Prohibition of the manufacture, sale of said drugs_Section
- Prohibition of the manufacture, sale or distribution of the Astemizole and Terfinadine for human_Section
- G.S.R 76E Amendment Schk_ Exemptions of Homeopathic hair oils, Cutom made devices, Zin sulphate Tabs
- Amendment in the notification regarding Prohibition of the manufacture, sale of Methaqualone_Section
- Suspension of the manufacture for sale, sale and distribution of Detyropropoxyphene and formulations containing Detyropropoxyphene for human use_Section
- Amendment to First Schedule_Section
- Drugs and Cosmetics (Amendment) Rules, 2018
- Suspension of the manufacture for sale, sale and distribution of Pioglitazone and all formulations containing Pioglitazone for human use_Section
- Reconstitution of Drugs Technical Advisory Board
- Drugs and Cosmetics (Second Amendment) Rules, 2018
- Prohibits the manufacture, sale or distribution of the Rosiglitazone and its formulation_Section
- amendment to First Schedule_Section
- Amendment in the notification regarding Prohibition of the manufacture, sale of FDC of Rifampicin, Isoniazide and pyraxinamide_Section
- Prohibition of the manufacture, sale of the Fixed Dose Combination of corticosteroidx with any other drug for internal use and fixed dose combination of Chloramphenicol with any other drug for internal use _Section
- Amendment Schedule K_addition of Homeopathic Hair Oils, omission of Arnica Montana hair oil_Sction
- Amendment in the notification regarding Prohibition of the manufacture, sale of Fixed dose combinationf ofHydroxyquinoline group of drugs with any other drug except for preparations meant for external use_Section _Section
- Prohibits the manufacture, sale or distribution of Fixed Dose Combination of Vitamin B, vitamin B6 and Vitamin B12 for human_Section
- Amendment to notification regarding Prohibition of the manufacture and sale of Fixed dose combination of Metoclopramide_Section
- Amendment in GSR 577(E) dated 23.7.1983
- Amendment in the notification regarding Prohibition of import of Rimonabant_Section
- Drugs and Cosmetics (Sixth Amendment) Rules, 2018
- Amendment SchY_Relating to Informed Consent_Section
- Drugs and Cosmetics (Fifth Amendment) Rules, 2018
- prohibits the manufacture and sale of parenteral preparations containing fixed dose combination of streptomycin with pencillins_Section
- Amendment of Rule 65A, Rule 97_Inclusion of Sch H1,Omission of said drugs from Sch H List_Section
- Amendment in the notification regarding Prohibition of the manufacture, sale of said drugs_Section
- Amendment of Rule 3A
- Amendment of Rule 43A_Addition of mumugao sea port and Goa, Bengaluru air port_Section
- Amendment Rule 157A
- Amendment to Form44
- Suspension of the manufacture for sale, sale and distribution of analgin and all formutation containing Analgin for human use_Section
- Amendment of Rule 2,122A,122B_Data to be submitted for Phytopharmaceuticals for CT_Section
- Amendment in the notification regarding Prohibition of the manufacture, sale fo FDC of crude Ergot preparation and Chloral Hydrate_Section
- Prohibition of the manufacture, sale of all Cosmetics Drugs licensed as tooth pastes, tooth powders containing tobacco_Section
- Insertion of Rule 122DAB, Appendix XII_Death Compensation_Section
- Manner of manufacture, sale, distribution of Oxytocin
- Revoke of suspension ondextropropoxyphene_Section 26_A D&C Act
- Amendment of Rule 122DA
- Insertion of Rule 134B_Prohibition of import of Cosmetics tested on animal_Section
- Amendment of Rule 43A_Section
- Amendment of Rule 71, 71A, 71B 76, 76A_Active
- Prohibits the manufacture, sale of distribution of hte said drugs_Section
- Amendment of drugs and Cosmetic Rules_Homoeopathy_Section
- Insertion of Rule 122DD_Registration of Ethics Committee_Section
- Amendment to notification regarding Prohibition of import Hydrochloride, Fenfluramine and Dexfenfluramine_Section
- Amendment in the Rule 49_Section
- Regulation and restiction of the manufacture, sale & Distribution of Oxytocin_Section
- Prohibits the manufacture, sale or distribution of the Rofecoxib and its formulation_Section